Dr. Julie Gerberding Named President of Merck's Vaccine Division
Dr. Julie Gerberding Named President of Merck's Vaccine Division

Ex-Director of the US Centers for Disease Control and Prevention, Dr. Julie Gerberding has been appointed as the new President of the vaccine division of Merck and Co Inc., as was confirmed by the company on Monday.

Dr. Gerberding had been CDC's leader from 2002 to 2009 and had stepped down from her position when President Barack Obama took office. Now, she will be taking into her hands the rein of Merck's $5 Billion global vaccine business which includes vaccines and shots for the prevention of chickenpox, cervical cancer and pneumonia.

"As a preeminent authority in public health, infectious diseases and vaccines, Dr. Gerberding is the ideal choice to lead Merck's engagement with organizations around the world that share our commitment to the use of vaccines to prevent disease and save lives", Merck Chief Executive Officer Richard Clark said.

Dr. Gerberding had led CDC through many crisis situations, including an investigation into the anthrax attacks that killed five people in 2001, and various outbreaks of food poisoning, among other serious issues.

Dr. Gerberding will be replacing Merck's previous head of vaccines Margaret McGlynn who recently retired.

Latest News

5000 Leprosy Cases Identified in Western Pacific
Genome Sequence Helps in Determining Breeding Crocs
India-EU Tug of War Continues
The New Electric Cheque
Google to Modernize its Networking Sites
Brothers Turn Blind Because of Leber's Optic Neuropathy
Snyder Students Keen on Resolving the Risk of Disease Outbreak
Valentine's Gifts Can Be Dangerous for Your Pets
Need to Go for Regular Dental Checkup
Women Must Take Good Care of Their Heart
Internet is Lovers’ Cupid
Healthy Looking Skin Attracts Women towards Men